Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 10,348 | 7,743 | 0 | 0 |
| Operating Income | -10,348 | -7,743 | N/A | N/A |
| Interest Expense | 96 | 102 | 0 | 0 |
| Pre-tax Income | -10,444 | -7,845 | 0 | 0 |
| Net Income Continuous | -10,444 | -7,845 | N/A | N/A |
| Net Income | $-10,444 | $-7,845 | $N/A | $N/A |
| EPS Basic Total Ops | -9.55 | -7.22 | N/A | N/A |
| EPS Basic Continuous Ops | -9.55 | -7.22 | N/A | N/A |
| EPS Diluted Total Ops | -9.55 | -7.22 | N/A | N/A |
| EPS Diluted Continuous Ops | -9.55 | -7.22 | N/A | N/A |
| EBITDA(a) | $-9,733 | $-7,222 | $N/A | $N/A |